Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial

被引：0
|
作者：
Nardo, Mirella
Reilley, Matthew
Biter, Amadeo
Lim, Joann
Bean, Stacie A.
Nguyen, Ly Minh
Bhosale, Priya
Ager, Casey
Couillault, Coline A.
Piha-Paul, Sarina A.
Fu, Siqing
Tsimberidou, Apostolia Maria
Yap, Timothy A.
Naing, Aung
Ahnert, Jordi Rodon
Subbiah, Vivek
Karp, Daniel D.
Curran, Michael A.
Hong, David S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Virginia, Charlottesville, VA USA
[3] Columbia Univ, Med Ctr, New York, NY USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2564
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    William Schelman
    Sherry Morgan-Meadows
    Howard Bailey
    Kyle Holen
    James P. Thomas
    Jens Eickhoff
    Heidi Brandon
    Kate Oliver
    Dona Alberti
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 727 - 733
  • [22] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Iqbal, Syma
    Lenz, Heinz-Josef
    Gandara, David R.
    Shibata, Stephen I.
    Groshen, Susan
    Synold, Timothy W.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 85 - 91
  • [23] Phase I trial of imexon (IMX) in patients (pts) with advanced solid tumors
    Dragovich, T
    Mendelson, D
    Gordon, M
    Long, K
    Downhour, M
    Dorr, R
    Hersh, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 229S - 229S
  • [24] A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors
    Liu, Stephen V.
    Groshen, Susan G.
    Kelly, Karen
    Reckamp, Karen L.
    Belani, Chandra
    Synold, Timothy W.
    Goldkorn, Amir
    Gitlitz, Barbara J.
    Cristea, Mihaela C.
    Gong, I-Yeh
    Semrad, Thomas J.
    Xu, Yucheng
    Xu, Tong
    Koczywas, Marianna
    Gandara, David R.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 723 - 732
  • [25] Phase I dose escalation trial of pegzilarginase in patients with advanced solid tumors
    Rasco, Drew W.
    Eckhardt, S. Gail
    Davar, Diwakar
    Lewis, Karl
    Lara-Guerra, Humberto
    Alters, Susan E.
    Eckert, Stephen
    Rowlinson, Scott W.
    Wooldridge, James E.
    Carvajal, Richard D.
    CANCER RESEARCH, 2018, 78 (13)
  • [26] A Phase I Trial of Bexarotene in Combination With Docetaxel in Patients With Advanced Solid Tumors
    Malik, Shakun M.
    Collins, Brian
    Pishvaian, Michael
    Ramzi, Pari
    Marshall, John
    Hwang, Jimmy
    CLINICAL LUNG CANCER, 2011, 12 (04) : 231 - 236
  • [27] Phase I trial of bortezomib in combination with ocetaxel in patients with advanced solid tumors
    Messersmith, WA
    Baker, SD
    Lassiter, L
    Sullivan, RA
    Dinh, K
    Almuete, VI
    Wright, JJ
    Donehower, RC
    Carducci, MA
    Armstrong, DK
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1270 - 1275
  • [28] Phase I trial of irinotecan and epirubicin in patients with advanced solid tumors.
    Gold, PJ
    Refice, S
    West, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 164S - 164S
  • [29] A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
    Yannis Metaxas
    Carmen Kahatt
    Vicente Alfaro
    Salvador Fudio
    Ali Zeaiter
    Ruth Plummer
    Cristiana Sessa
    Roger Von Moos
    Martin Forster
    Anastasios Stathis
    Investigational New Drugs, 2022, 40 : 91 - 98
  • [30] A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
    Metaxas, Yannis
    Kahatt, Carmen
    Alfaro, Vicente
    Fudio, Salvador
    Zeaiter, Ali
    Plummer, Ruth
    Sessa, Cristiana
    Von Moos, Roger
    Forster, Martin
    Stathis, Anastasios
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 91 - 98
12345